Physician

Afif Hentati, MD

According to 2025 Medicare claims, Afif Hentati, MD (NPI: 1417008483) practices neurology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60201-1780.

Hentati's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 544 traditional Medicare patients, billed 1,008 HCPCS/CPT codes, and received $75,994 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,616 prescription claims across 486 beneficiaries totaling $3,778,606 in drug costs, led by Zeposia (Ozanimod Hydrochloride). DME data shows 33 claims. Open Payments data shows 47 records totaling $69,266. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	349	660	$47,141
2016	430	788	$61,053
2017	433	825	$67,735
2018	461	827	$68,352
2019	485	831	$67,017
2020	453	773	$58,938
2021	476	821	$79,416
2022	517	870	$81,170
2023	558	851	$76,877
2024	544	1,008	$75,994

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	220	2,373	$3,228,374
2016	231	2,565	$3,407,258
2017	268	2,689	$4,248,172
2018	276	2,936	$4,492,660
2019	345	3,131	$4,510,588
2020	366	3,569	$5,765,437
2021	373	3,502	$5,398,824
2022	394	3,397	$4,153,748
2023	425	3,368	$3,936,988
2024	486	3,616	$3,778,606

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$514
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$2,494
2024	N/R	33	$25,664

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	45	45	$135
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	153	194	$109
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	48	48	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	303	429	$72
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	121	138	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Zeposia	Ozanimod Hydrochloride	61	2,084	$611,226
Tecfidera	Dimethyl Fumarate	39	1,410	$427,860
Vumerity	Diroximel Fumarate	50	1,393	$389,739
Plegridy Pen	Peginterferon Beta-1a	39	1,092	$325,978
Copaxone	Glatiramer Acetate	49	1,596	$323,845

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	11	$25,202
K0003	Lightweight wheelchair	Y	N/R	11	$362
K0195	Elevating leg rests, pair (for use with capped rental wheelchair base)	Y	N/R	11	$101

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$12,760	Biogen, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	29	$56,506	Northshore University Healthsystem
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Afif Hentati, MD?

Tedicare shows public-source Medicare data for Afif Hentati, MD (NPI 1417008483), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afif Hentati, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Afif Hentati, MD?

Afif Hentati, MD is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Afif Hentati, MD have Open Payments data?

Afif Hentati, MD has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.